Testosterone bolsters insulin sensitivity in men with diabetes

05/6/2013 | MedPage Today (free registration)

Testosterone replacement therapy fared better than placebo in boosting insulin sensitivity in men with type 2 diabetes and hypogonadotropic hypogonadism, a study presented at the American Association of Clinical Endocrinologists annual meeting revealed. Researchers also found those who underwent testosterone treatment showed better lean mass, total fat, C-reactive protein and free fatty acids compared with those in the placebo group.

View Full Article in:

MedPage Today (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ